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METABOLISM OF LIPIDS AND 3-ACETYLPYRIDINE
W I L L I A M T . BEHER

Since completion of research for a doctoral thesis (26) in this Department, the
writer, with Mr. William L. Anthony and Mrs. Gizella Baker as collaborators, has
engaged in 3 principal lines of investigation which are briefly discussed below.
I.

Metabolism of 3-Acetylpyridine

Reference has already been made (page 122) to studies in which labehng with
carbon-13 was employed to demonstrate in vivo conversion of 3-acetylpyridine to a
labeled nicotinic acid derivative. The question arose whether during the metabolism
of 3 A.CP. to N^-methyl nicotinamide, the methyl group of 3 A.C.P. was transmethylated to suitable acceptors or oxidized. To answer this question, a new and
highly successful organic synthetic method of labeling the methyl group with C-14
was developed. When the resulting compound was administered to rats and the
expired CO2 collected, about 20% of the injected activity could be accounted for in
the first 8 hours after injection — the bulk of it in the first 6 hours — indicating a
rapid oxidation. While a considerable amount of activity was excreted in the urine
(40% of injected activity in 24 hours), none was detected in the feces. Urinarv
C-14 activity was not present as HCO a or unaltered 3 A.CP., but only as a urinary
product which has not yet been isolated. This substance seems to be an amino acid
or other amphoteric compound.
In a series of in vitro studies, the tissues responsible for the oxidation of 3 A.C.P.
are being investigated. Tissue slices of liver, kidney, muscle, and spleen are incubated
in Ringer's solution containing C-14 3 A.C.P. The CO2 produced is collected and
assayed for C-14 activity. Preliminary results indicate active metabolism in the
liver and kidney with little or none in the spleen or muscle. Because of the number
of probable steps necessary for oxidation, combination studies (kidney -|- liver) are
contemplated. It is hoped that these studies will eventually lead to an understanding
of the mechanism of single methyl oxidation.
Studies on the effects of 3 A.C.P. on enzyme systems requiring Co I and I I
have been completed. I f the substitution antimetabolite theory applied in these cases,
one would expect 3 A.C.P. to inhibit these reactions. However, in a study of glucolysis
by R B C's, this did not occur even with 1 % of 3 A.C.P. Moreover, synthesis rates
of cholesterol and lipids in liver slices, as indicated by C-14 uptake, were retarded
only at high 3 A.C.P. concentrations. It thus seems that 3 A.C.P. does not function
by substitution in DPN or TPN (at least in the systems studied).
3 A.C.P. is extremely toxic in rats at the 15 mg per day dose level, but this
toxicity can be reversed by prior (but not simultaneous) administration of nicotinamide.
Theoretically this might be explained by a buildup of enzyme systems containing
DPN or TPN which oxidize 3 A.C.P. to niacin and its derivatives. Experiments on
oxidation rates of C-14 (methyl) labeled 3 A.C.P. indicate a slightly increased rate
of oxidation of 3 A.C.P. in the animals pretreated with nicotinamide.
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2.
a. Experimental

Studies of Lipid Metabolism

Atherosclerosis.

It is known that experimental atherosclerosis can be produced with varying
degrees of ease in different species. For example, while dietary cholesterol alone is
sufficient in the case of the normal chick and rabbit, in the case of dogs and rats
this substance will produce hypercholesterolemia and atherosclerosis only in the
presence of hypothyroidism. Therefore, it seems possible that hypophysectomized
rats, which due to the absence of the thyrotrophic activity lack the thyroid hormone,
might be especially susceptible to experimental atherosclerosis. Since such animals
are also deficient in many other hormones such as adrenal corticotrophic hormone,
growth hormone, and the gonadotrophic hormones, the effects of these substances
on the production and regression of experimental atherosclerosis can also be studied.
Studies previously carried out (135, 149) have shown that the extremely slow
turnover rate of cholesterol and other lipids in the rabbit aorta, make this species
unsatisfactory for the study of regression of aortic plaques. In some cases actual
increases in plaque area and total lipids were observed during the regression period.
These increases were probably due to the deposition of excess blood lipids. Therefore,
while it is possible that satisfactory studies might be undertaken if sufficient time were
allowed to clear the excess blood and liver lipid, the turnover rate would probably
remain much too slow for satisfactory results. A literature survey indicates that the
chick might prove a satisfactory species for the study of aortic plaque regression,
because of the higher turnover rate of lipids in its aorta. While the above outlined
experiments on hypophysectomized rats should prove very valuable in the study of
hormonal effects, we believe that the chick will be much more satisfactory in studying
aorta plaque regression as influenced by such substances as /^-sitosterol, choline, and
surface active agents.

b. Cholesterol

Metabolism

Perhaps one of the most important groups of compounds concerned with the
endogenous metabohsm of cholesterol, are the bile acids. These substances are not
only of major importance in the primary absorption and intestinal hepatic recycling
of cholesterol, but also appear to have a definite influence on the rate of mobilization,
metabolism and tissue distribution of cholesterol. For example, we have shown (83)
that bile acids added to a lipid-free diet, supplemented with cholesterol, increase the
cholesterol deposition in mice livers. In other experiments not yet reported, dietary
cholic acid retarded the mobilization of accumulated liver cholesterol in the mouse.
These phenomena may be interdependent or independent; that is, cholic acid may
act on cholesterol in either of two ways: (a) it may increase the absorption rate;
or (b) it may decrease the degradation rate. To investigate these problems, three
experiments will be carried out:
1. Absorption of cholesterol in the presence of varying amounts of cholic acid
in mice.
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2. The influence of cholic acid on the rate of cholesterol metabolism in the
normal rat.
3. The influence of cholic acid on the rate of cholesterol catabolism in rats with
elevated liver cholesterol.
c. Studies of Substances which Inhibit Cholesterol Synthesis and

Ab.wrption.

Since high cholesterol levels are associated with atherosclerosis, substances which
lower serum and tissue cholesterol are being sought and investigated. In this laboratory
(83, 109, 135, 149) both /J-sitosterol and dihydrocholesterol were found effective in
lowering serum and liver cholesterol. However, dihydrocholesterol, in addition, showed
toxic effects. The extent and severity of these are currently being investigated in a
joint project with the Pathology Department of Henry Ford Hospital.
In another approach to this problem, an effort is being made to find a substance
which will inhibit the synthesis of cholesterol in an organism. Since the intermediates
in the synthesis of cholesterol have recently been discovered, we wish to synthesize
several derivatives of these and test their activity as antimetabolites.
3. Analytical Studies Using Infrared Spectroscopy
These are discussed in the article by Jonathan Parsons (Page 99) with whom the
writer collaborated.
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